Medical therapy for children with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 2, Issue 4, 1996, Pages 269-275

  Winter, Harland ^a,b   Grand, Richard ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000011633     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020410     Document Type: Review

References (46)

1. Motil KJ, Grand RJ. Ulcerative colitis and Crohn's disease in children. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease, 4th ed. Philadelphia: Lea & Febiger, 1988:227-38.
2. Ferry GD, Kirschner BS, Grand RJ, et al. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: Results of the Pediatric Gastroenterology Collaborative Research Group Clinical Trials. Pediatr Gastroenterol Nutr 1993;17:32-8.
3. Hyams JS, Davis P, Grancher K, Lerer T, Justinich CJ, Markowitz J. Clinical outcome of ulcerative colitis in children. J Pediatr 1996; 129:81-8.
4. Grand RJ, Ramakrishna J, Calenda KA. Inflammatory bowel disease in the pediatric patient. Gastroenterol Clin North Am 1995; 24:613-32.
5. Barden L, Lipson A, Pert P, et al. Mesalazine in childhood inflammatory bowel disease. Aliment Pharmacol Ther 1989;3:597-603.
6. Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992;103:51-6.
7. Kirschner BS. Ulcerative colitis in children. Pediatr Clin North Am 1996;43:235-54.
8. Treem WR, Davis PM, Hyams JS. Cyclosporine treatment of severe ulcerative colitis in children. J Pediatr 1991;119:994-7.
9. Sandborn WJ, Goldman DH, Lawson GM, et al. Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 1992;15:125-9.
10. Ramakirshna J, Langhans N, Calenda K. Combined use of cyclosporine A and azathioprine in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1996;22:296-302.
11. Kirschner BS, Whitington PF, Malfeo-Klein R. Experience with cyclosporine A (CyA) in severe non-specific ulcerative colitis (ulcerative colitis). Pediatr Res 1989;25:A117.
12. Werlin SL, Grand RJ. Severe colitis in children and adolescents: Diagnosis, course and treatment. Gastroenterology 1977;73:828-32.
13. Seashore JH, Hillemeier AC, Gryboski JD. Total parenteral nutrition in the management of inflammatory bowel disease in children: A limited role. Am J Surg 1982;143:504-7.
14. Gold DM, Levine JJ, Pettei MJ. Prolonged medical therapy for severe ulcerative colitis. Am J Gastroenterol 1995;90:732-5.
15. Winter HS. When does a child with severe ulcerative colitis need a surgeon? Inflammatory Bowel Diseases 1996;2:159.
16. Kirschner BS. Ulcerative colitis in children. Pediatr Clin North Am 1996;43:235-54.
17. Sadeghi-Nejad A, Senior B. The treatment of ulcerative colitis in children with alternate-day corticosteroids. Pediatrics 1969;43: 840-5.
18. Markowitz J, Rosa J, Grancher K, et al. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology 1990;99:1347-51.
19. Verhave M, Winter HS, Grand RJ. Azathioprine in the treatment of children with inflammatory bowel disease. J Pediatr 1990;117: 809-14.
20. Lofberg R, Thomsen O, Ostergaard X, Langholz E, et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1994;8:623-9.
21. Hyams JS. Crohn's disease in children. Pediatr Clin N Am 1996; 43:255-77.
22. Biller JA, Grand RJ, Harris BH. Abdominal abscesses in adolescents with Crohn's disease. J Pediatr Surg 1987;22:873-6.
23. Markowitz J, Daum F, Alger M, et al. Perinatal disease in children and adolescents with Crohn's disease. Gastroenterology 1984;86: 829-33.
24. Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporine A. Am J Gastroenterol 1993;88:646-9.
25. Derkx B, Taminiau JJM, Radema S, et al. Tumor necrosis factor antibody treatment in Crohn's disease. Lancet 1993;342:173-4.
26. vanDullemen MH, vanDeventer SJH, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
27. Motil KJ, Grand RJ, Davis-Kraft L, et al. Growth failure in children with inflammatory bowel disease: a prospective study. Gastroenterology 1993;105:681-91.
28. Hildebrand H, Karlberg J, Kristiansson B, et al. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18:165-73.
29. Seidman EG, Lohoues MJ, Turgeon J, et al. Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long-term results. Gastroenterology 1991;100:A250.
30. Seidman E. Nutritional management of inflammatory bowel disease. Gastroenterol Clin N Am 1989;17:129-55.
31. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988;94:603-10.
32. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995;108:1056-67.
33. Cezard JP, Touati G, Hugot JP, et al. Nutritional treatment in pediatric IBD. In: Tytgat GNJ, Bartelsman JFWM, vanDeventer SJH, eds. Inflammatory bowel disease. Dordrecht: Kluwer Academic 1995:619-25.
34. Kirschner BS, DeFavaro MV, Jensen W. Lactose malabsorption in children and adolescents with inflammatory bowel disease. Gastroenterology 1981;81:829-32.
35. Telander RL. Surgical management of inflammatory bowel disease in children. In: Telander R, ed. Problems in general surgery. Vol. 10. Philadelphia: JB Lippincott, 1993:136-46.
36. Fonkalsrud EW. Surgical management of ulcerative colitis in childhood. Semin Pediatr Surg 1994;3:33-9.
37. Landholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11.
38. Davies G, Evans CM, Shand WS, et al. Surgery for Crohn's disease in childhood: Influence of site of disease and operative procedure on outcome. Br J Surg 1990;77:891-4.
39. Michener WM, Farmer RG, Mortimer EA. Long-term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979;1:301-5.
40. Ekbom A, Helmick CG, Zack M, et al. Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 1992;103:954-60.
41. Lashner BA, Heidenreich PA, Su GL, et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis - a case control study. Gastroenterology 1989; 97:255-9.
42. Meenan J, O'Hallinan E, Scott J, Weir DG. Influence of sulfasalazine and olsalamine on colonic epithelial cell folate content in patients with ulcerative colitis. Inflammatory Bowel Diseases 1996;2:163-7.
43. Hanauer SB. Medical therapy in ulcerative colitis. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Baltimore: Williams and Wilkins, 1995:664-94.
44. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60.
45. D'Amato RJ, Loughnan MS, Flynn E, et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994;91: 4082-5.
46. Weiner HL, Friedman A, Miller A, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific, autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 1994;12:809-37.